Hemagen Diagnostics, Inc.
HMGN · OTC
9/30/2012 | 9/30/2011 | 9/30/2010 | 9/30/2009 | |
|---|---|---|---|---|
| Revenue | $4,042 | $5,141 | $5,220 | $5,419 |
| % Growth | -21.4% | -1.5% | -3.7% | – |
| Cost of Goods Sold | $2,429 | $3,180 | $2,864 | $3,347 |
| Gross Profit | $1,613 | $1,961 | $2,356 | $2,072 |
| % Margin | 39.9% | 38.1% | 45.1% | 38.2% |
| R&D Expenses | $45 | $5 | $25 | $92 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,007 | $2,429 | $2,095 | $2,329 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,051 | $2,434 | $2,120 | $2,421 |
| Operating Income | -$438 | -$473 | $236 | -$349 |
| % Margin | -10.8% | -9.2% | 4.5% | -6.4% |
| Other Income/Exp. Net | -$469 | -$404 | -$303 | -$360 |
| Pre-Tax Income | -$907 | -$876 | -$67 | -$709 |
| Tax Expense | $0 | $4 | $90 | $21 |
| Net Income | -$907 | -$880 | -$156 | -$808 |
| % Margin | -22.4% | -17.1% | -3% | -14.9% |
| EPS | -0.059 | -0.06 | -0.01 | -0.05 |
| % Growth | 2.5% | -500% | 80% | – |
| EPS Diluted | -0.059 | -0.06 | -0.01 | -0.05 |
| Weighted Avg Shares Out | 15,499 | 15,476 | 15,454 | 15,235 |
| Weighted Avg Shares Out Dil | 15,499 | 15,476 | 15,454 | 15,235 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $469 | $407 | $332 | $404 |
| Depreciation & Amortization | $164 | $186 | $164 | $157 |
| EBITDA | -$274 | -$284 | $429 | -$192 |
| % Margin | -6.8% | -5.5% | 8.2% | -3.5% |